NeuBase Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBSE and other ETFs, options, and stocks.

About NBSE

NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. 

CEO
Dietrich A. Stephan
CEODietrich A. Stephan
Employees
33
Employees33
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2009
Founded2009
Employees
33
Employees33

NBSE Key Statistics

Market cap
7.77M
Market cap7.77M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
297.35K
Average volume297.35K
High today
$0.275
High today$0.275
Low today
$0.235
Low today$0.235
Open price
$0.24
Open price$0.24
Volume
48.41K
Volume48.41K
52 Week high
$3.24
52 Week high$3.24
52 Week low
$0.184
52 Week low$0.184

NBSE Earnings

-$0.30
-$0.20
-$0.10
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Dec 22, Pre-Market
ActualExpected Dec 22, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.